Euroopa Liit - saksa - EMA (European Medicines Agency)

warner chilcott uk ltd. - testosteron - sexuelle funktionsstörungen, psychologische - sexualhormone und modulatoren des genital-system, - intrinsa ist in bilateral oophorectomised und hysterectomised (chirurgisch induzierter menopause) frauen, die begleitende Östrogen-therapie für die behandlung der Überfunktion sexuelles verlangen disorder (hsdd) angegeben..

Euroopa Liit - saksa - EMA (European Medicines Agency)

intervet international bv - azagly-nafarelin - hormone und analoga der hypophyse und des hypothalamus - dogs; salmonidae (salmonid fish) - weiblichen lachsartigen fischen wie atlantischer lachs (salmo salar), regenbogenforelle (oncorhynchus mykiss), bachforelle (salmo trutta) und arctic charr (salvelinus alpinus)die induktion und synchronisation der ovulation zur produktion von augen-eier und braten. hunde (hündinnen)prävention der funktion der gonaden bei den hündinnen über langfristige blockade der gonadotropin-synthese.

Euroopa Liit - saksa - EMA (European Medicines Agency)

vivus bv - phentermine, topiramat - fettleibigkeit

Euroopa Liit - saksa - EMA (European Medicines Agency)

sanofi b.v. - thyrotropin alfa - schilddrüsenneoplasmen - vorderen hypophysenlappens hormone und analoga hypophysen-und hypothalamus-hormone und analoga - thyrogen is indicated for use with serum thyroglobulin (tg) testing with or without radioiodine imaging for the detection of thyroid remnants and well-differentiated thyroid cancer in post thyroidectomy patients maintained on hormone suppression therapy (thst). low risk patients with well-differentiated thyroid carcinoma who have undetectable serum tg levels on thst and no rh (recombinant human) tsh-stimulated increase of tg levels may be followed-up by assaying rh tsh-stimulated tg levels. thyrogen is indicated for pre-therapeutic stimulation in combination with a range of 30 mci (1. 1 gbq) to 100 mci (3. 7 gbq) radioiodine for ablation of thyroid tissue remnants in patients who have undergone a near-total or total thyroidectomy for well-differentiated thyroid cancer and who do not have evidence of distant metastatic thyroid cancer (see section 4.

Euroopa Liit - saksa - EMA (European Medicines Agency)

pfizer europe ma eeig - somatrogon - growth and development - hypophysen-und hypothalamus-hormone und analoga - indicated for the long-term treatment of paediatric patients with growth disturbance due to insufficient secretion of growth hormone.

Euroopa Liit - saksa - EMA (European Medicines Agency)

astellas pharma europe b.v. - enzalutamid - prostata-neoplasmen - endokrine therapie - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.

Šveits - saksa - OFAG-BLW (Bundesamt für Landwirtschaft)

agro seller discount ag - chlorothalonil (tcpn); azoxystrobin - gp 005748-00/006 - deutschland - fungizid ;

Šveits - saksa - OFAG-BLW (Bundesamt für Landwirtschaft)

syngenta agro gmbh - chlorothalonil (tcpn); azoxystrobin - 005748-00 - deutschland - fungizid ;

Šveits - saksa - OFAG-BLW (Bundesamt für Landwirtschaft)

arysta lifescience switzerland sàrl - chlorothalonil (tcpn); 1,2-benzisothiazol-3(2h)-one; 1,2-benzisothiazolin-1 3-one - scsuspensionskonzentrat - 54.4 %720 g/l; ; - fungizid ;

Šveits - saksa - OFAG-BLW (Bundesamt für Landwirtschaft)

arysta lifescience - chlorothalonil (tcpn) - 8800488 - frankreich - fungizid ;